Outside the patent monopolies – Indian Express
Indian Express |
Outside the patent monopolies
Indian Express Novartis’s drug Glivec was denied patent protection by the Supreme Court and India granted a compulsory licence to Bayer’s drug Nexavar, which treats kidney and liver cancer. Compulsory licences are a provision in international patent norms, including … |